A Catalyzing Phantom for Reproducible Dynamic Conversion of Hyperpolarized [1-13C]-Pyruvate

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Walker, Christopher M ^a   Lee, Jaehyuk ^a   Ramirez, Marc S ^a   Schellingerhout, Dawid ^a   Millward, Steven ^a   Bankson, James A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENZYME; ISOTOPE; LACTIC ACID; PYRUVATE CARBON 1-13; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE MODEL; HYPERPOLARIZATION; IMAGING; IMAGING PHANTOM; IN VIVO STUDY; ISOTOPE LABELING; MEASUREMENT; NEOPLASM; PERSONALIZED MEDICINE; PHYSIOLOGICAL PROCESS; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SPECTROSCOPY;

ANIMALS; CARBON ISOTOPES; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; PHANTOMS, IMAGING; PYRUVIC ACID;

EID: 84881573357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071274     Document Type: Article

References (41)

1. Morse DL, Gillies RJ, (2010) Molecular imaging and targeted therapies. Biochem Pharmacol 80: 731-738.
2. Abragam A, Goldman M, (1978) Principles of Dynamic Nuclear-Polarization. Reports on Progress in Physics 41: 395-467.
3. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, et al. (2003) Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100: 10158-10163.
4. Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, et al. (2011) Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 13: 81-97.
5. Hu S, Lustig M, Chen AP, Crane J, Kerr A, et al. (2008) Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J Magn Reson 192: 258-264.
6. Larson PE, Hu S, Lustig M, Kerr AB, Nelson SJ, et al. (2011) Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies. Magn Reson Med 65: 610-619.
7. Ohliger MA, Larson PE, Bok RA, Shin P, Hu S, et al. (2013) Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance spectroscopic imaging (MRSI). J Magn Reson Imaging: In press.
8. Mayer D, Yen YF, Tropp J, Pfefferbaum A, Hurd RE, et al. (2009) Application of subsecond spiral chemical shift imaging to real-time multislice metabolic imaging of the rat in vivo after injection of hyperpolarized 13C1-pyruvate. Magn Reson Med 62: 557-564.
9. Levin YS, Mayer D, Yen YF, Hurd RE, Spielman DM, (2007) Optimization of fast spiral chemical shift imaging using least squares reconstruction: application for hyperpolarized (13)C metabolic imaging. Magn Reson Med 58: 245-252.
10. Cunningham CH, Chen AP, Albers MJ, Kurhanewicz J, Hurd RE, et al. (2007) Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson 187: 357-362.
11. Hu S, Lustig M, Balakrishnan A, Larson PE, Bok R, et al. (2010) 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med 63: 312-321.
12. Arunachalam A, Whitt D, Fish K, Giaquinto R, Piel J, et al. (2009) Accelerated spectroscopic imaging of hyperpolarized C-13 pyruvate using SENSE parallel imaging. NMR Biomed 22: 867-873.
13. Larson PE, Bok R, Kerr AB, Lustig M, Hu S, et al. (2010) Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. Magn Reson Med 63: 582-591.
14. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
15. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899.
16. Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, et al. (2008) Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res 68: 8607-8615.
17. Day SE, Kettunen MI, Gallagher FA, Hu DE, Lerche M, et al. (2007) Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 13: 1382-1387.
18. Bohndiek SE, Kettunen MI, Hu DE, Brindle KM, (2012) Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization. Cancer Res 72: 854-864.
19. Park I, Bok R, Ozawa T, Phillips JJ, James CD, et al. (2011) Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. J Magn Reson Imaging 33: 1284-1290.
20. Witney TH, Kettunen MI, Brindle KM, (2011) Kinetic modeling of hyperpolarized 13C label exchange between pyruvate and lactate in tumor cells. J Biol Chem 286: 24572-24580.
21. Yagil G, Hoberman HD, (1969) Rate of isotope exchange in enzyme-catalyzed reactions. Biochemistry 8: 352-360.
22. Zewe V, Fromm HJ, (1962) Kinetic studies of rabbit muscle lactate dehydrogenase. J Biol Chem 237: 1668-1675.
23. Zewe V, Fromm HJ, (1965) Kinetic Studies of Rabbit Muscle Lactate Dehydrogenase. Ii. Mechanism of the Reaction. Biochemistry 4: 782-792.
24. Sun F, Dai C, Xie J, Hu X, (2012) Biochemical issues in estimation of cytosolic free NAD/NADH ratio. PLoS One 7: e34525.
25. Harris T, Eliyahu G, Frydman L, Degani H, (2009) Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells. Proc Natl Acad Sci U S A 106: 18131-18136.
26. Harrison C, Yang C, Jindal A, DeBerardinis RJ, Hooshyar MA, et al. (2012) Comparison of kinetic models for analysis of pyruvate-to-lactate exchange by hyperpolarized 13 C NMR. NMR Biomed 25: 1286-1294.
27. Kazan SM, Reynolds S, Kennerley A, Wholey E, Bluff JE, et al. (2012) Kinetic modeling of hyperpolarized (13) C pyruvate metabolism in tumors using a measured arterial input function. Magn Reson Med: in press.
28. Brindle KM, (1988) NMR Methods for Measuring Enzyme Kinetics in Vivo. Progress in Nuclear Magnetic Resonance Spectroscopy 20: 36.
29. Ward CS, Venkatesh HS, Chaumeil MM, Brandes AH, Vancriekinge M, et al. (2010) Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res 70: 1296-1305.
30. Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, et al. (2012) Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 11: 1373-1380.
31. Zhao L, Mulkern R, Tseng CH, Williamson D, Patz S, et al. (1996) Gradient-echo imaging considerations for hyperpolarized 129Xe MR. J Magn Reson B 113: 179-183.
32. Thind K, Chen A, Friesen-Waldner L, Ouriadov A, Scholl TJ, et al. (2012) Detection of radiation-induced lung injury using hyperpolarized (13) C magnetic resonance spectroscopy and imaging. Magn Reson Med: in press.
33. Lodi A, Woods SM, Ronen SM, (2013) Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells. NMR Biomed 26: 299-306.
34. Clatworthy MR, Kettunen MI, Hu DE, Mathews RJ, Witney TH, et al. (2012) Magnetic resonance imaging with hyperpolarized [1,4-(13)C2]fumarate allows detection of early renal acute tubular necrosis. Proc Natl Acad Sci U S A 109: 13374-13379.
35. Bohndiek SE, Kettunen MI, Hu DE, Witney TH, Kennedy BW, et al. (2010) Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy. Mol Cancer Ther 9: 3278-3288.
36. Matsumoto S, Saito K, Yasui H, Morris HD, Munasinghe JP, et al. (2013) EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn Reson Med 69: 1443-1450.
37. Lau AZ, Chen AP, Barry J, Graham JJ, Dominguez-Viqueira W, et al. (2013) Reproducibility study for free-breathing measurements of pyruvate metabolism using hyperpolarized (13) C in the heart. Magn Reson Med 69: 1063-1071.
38. Bergmeyer HU, Gawehn K (1983) Methods of Enzymatic Analysis. Weinheim; Deerfield Beach, FL: Verlag Chemie.
39. Reynolds S, Kazan S, Bluff J, Port M, Wholey E, et al. (2012) Fully MR-Compatible Syringe Pump for the Controllable Injection of Hyperpolarized Substrate in Animals. Applied Magnetic Resonance 43: 263-273.
40. Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC, Aerts HJ, et al. (2011) Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology 259: 875-884.
41. Laustsen C, Ostergaard JA, Lauritzen MH, Norregaard R, Bowen S, et al. (2013) Assessment of early diabetic renal changes with hyperpolarized [1-(13) C]pyruvate. Diabetes Metab Res Rev 29: 125-129.